Q1 2026 Earnings Call May 5, 2026 10:00 AM EDTCompany ParticipantsStephen Vather - Senior VP of Corporate Development ...
SG&A expenses -- $29.2 million, rising from $22.7 million; driven mainly by increased intangible amortization from the Assage ...
KT-621 (STAT6) parallel Phase 2b trials, BROADEN2 in atopic dermatitis and BREADTH in asthma, ongoing with data expected by mid-2027 and late ...
According to Rogers, the computer science faculty use Gradescope’s Measure Of Software Similarity (MOSS) tool to identify ...
Economist Scott Cunningham showed the Fed how AI agents can replicate studies for $11—and why the same tools could erode the ...
Q3 2026 Earnings Call April 30, 2026 4:30 PM EDTCompany ParticipantsIvan Donaldson - Vice President of Investor RelationsDavid V.
Soaring gold prices, viral panning influencers, macho gold-mining reality shows, and Trump’s gold obsession have ignited a ...
Machine learning sounds math-heavy, but modern tools make it far more accessible. Here’s how I built models without deep math ...
Ireland has evolved into one of the world’s most critical locations for the global Pharmaceutical Industry. Today, with more ...
U.S. Mitapivat Net Revenue -- $18.8 million, attributed to initial AQVESME demand. Operating Expenses -- R&D was $81 million, ...
Eduard Viladesau, Managing Director, HIPRA Biotech Services, highlights how the company brings engineered flexibility to the ...
Operator: Good day, and thank you for standing by. Welcome to the First Quarter 2026 Agios Financial Results and Business ...